SUVRETTA CAPITAL MANAGEMENT, LLC - Q3 2021 holdings

$5.94 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 106 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 100.0% .

 Value Shares↓ Weighting
ARYD ExitARYA SCIENCES ACQU CORP IVcl a$0-100,000
-100.0%
-0.02%
EOCWU ExitELLIOTT OPPORTUNITY II CORPunit 99/99/9999$0-150,000
-100.0%
-0.02%
WPFWS ExitFOLEY TRASIMENE ACQUISTN COR*w exp 05/26/202$0-774,375
-100.0%
-0.02%
SANA ExitSANA BIOTECHNOLOGY INC$0-100,000
-100.0%
-0.03%
CLII ExitCLIMATE CHANGE CRISIS REAL I$0-200,000
-100.0%
-0.04%
MCW ExitMISTER CAR WASH INC$0-150,000
-100.0%
-0.05%
GLUE ExitMONTE ROSA THERAPEUTICS INC$0-150,000
-100.0%
-0.05%
TBLA ExitTABOOLA.COM LTD$0-350,000
-100.0%
-0.05%
CYT ExitCYTEIR THERAPEUTICS INC$0-175,000
-100.0%
-0.06%
GRPH ExitGRAPHITE BIO INC$0-125,000
-100.0%
-0.06%
FIVE ExitFIVE BELOW INC$0-30,636
-100.0%
-0.09%
VERV ExitVERVE THERAPEUTICS INC$0-100,000
-100.0%
-0.09%
NHIC ExitNEWHOLD INVESTMENT CORP$0-750,706
-100.0%
-0.11%
TPTX ExitTURNING POINT THERAPEUTICS I$0-122,994
-100.0%
-0.14%
ALUS ExitALUSSA ENERGY ACQUISITION CO$0-1,000,000
-100.0%
-0.15%
HOL ExitHOLICITY INC$0-1,000,000
-100.0%
-0.18%
OWL ExitBLUE OWL CAPITAL INC$0-1,000,000
-100.0%
-0.19%
MQ ExitMARQETA INC$0-503,898
-100.0%
-0.21%
FBRX ExitFORTE BIOSCIENCES INC$0-516,956
-100.0%
-0.26%
FTCV ExitFINTECH ACQUISITION CORP V$0-1,661,845
-100.0%
-0.30%
AGC ExitALTIMETER GROWTH CORPcl a$0-1,753,264
-100.0%
-0.31%
RACA ExitTHERAPEUTICS ACQUISITION COR$0-2,045,600
-100.0%
-0.31%
AMAM ExitAMBRX BIOPHARMA INCsponsored ads$0-1,169,529
-100.0%
-0.34%
RAAC ExitREVOLUTION ACCELERTN ACQU CO$0-2,500,708
-100.0%
-0.37%
SOFI ExitSOFI TECHNOLOGIES INCput$0-1,440,000
-100.0%
-0.41%
S ExitSENTINELONE INCcl a$0-701,000
-100.0%
-0.45%
AJAX ExitAJAX I$0-3,002,193
-100.0%
-0.45%
KPLT ExitKATAPULT HOLDINGS INC$0-3,004,034
-100.0%
-0.49%
GPN ExitGLOBAL PMTS INC$0-206,753
-100.0%
-0.58%
BLUE ExitBLUEBIRD BIO INC$0-1,252,575
-100.0%
-0.60%
GHVI ExitGORES HOLDINGS VI INC$0-2,651,800
-100.0%
-0.64%
SOFI ExitSOFI TECHNOLOGIES INC$0-2,500,000
-100.0%
-0.72%
NVTA ExitINVITAE CORP$0-1,719,944
-100.0%
-0.87%
EXAS ExitEXACT SCIENCES CORP$0-487,400
-100.0%
-0.91%
WPF ExitFOLEY TRASIMENE ACQUISTN COR$0-8,048,673
-100.0%
-1.18%
VMEO ExitVIMEO INC$0-1,639,972
-100.0%
-1.20%
FIS ExitFIDELITY NATL INFORMATION SV$0-600,000
-100.0%
-1.27%
AAPL ExitAPPLE INC$0-727,500
-100.0%
-1.49%
PSFE ExitPAYSAFE LIMITEDord$0-12,917,328
-100.0%
-2.34%
FB ExitFACEBOOK INCcl a$0-463,280
-100.0%
-2.41%
UBER ExitUBER TECHNOLOGIES INC$0-3,859,494
-100.0%
-2.89%
GOOG ExitALPHABET INCcap stk cl c$0-107,169
-100.0%
-4.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2021-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-05-02
SC 13D2024-04-29
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings